In conclusion, our findings suggest potential therapeutic benefits of ATRA in Alzheimer’s disease, highlighting the importance of further research into tau internalization and degradation mechanisms. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.